Citation Tools
Original research
Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study